372 related articles for article (PubMed ID: 22138687)
21. [Effect of Intravitreal Bevacizumab Injection on Iris and Iridocorneal Angle Neovascularization in Neovascular Glaucoma].
Ishibashi S; Kondo H
J UOEH; 2015 Dec; 37(4):299-304. PubMed ID: 26667197
[TBL] [Abstract][Full Text] [Related]
22. NEOVASCULAR SECONDARY GLAUCOMA, ETIOLOGY AND PATHOGENESIS.
Barac IR; Pop MD; Gheorghe AI; Taban C
Rom J Ophthalmol; 2015; 59(1):24-8. PubMed ID: 27373111
[TBL] [Abstract][Full Text] [Related]
23. Congenital ectropion uvea and mechanisms of glaucoma in neurofibromatosis type 1: new insights.
Edward DP; Morales J; Bouhenni RA; Patil J; Edward PR; Cummings TJ; Chaudhry IA; Alkatan H
Ophthalmology; 2012 Jul; 119(7):1485-94. PubMed ID: 22480745
[TBL] [Abstract][Full Text] [Related]
24. A review of neovascular glaucoma. Etiopathogenesis and treatment.
Dumbrăveanu L; Cușnir V; Bobescu D
Rom J Ophthalmol; 2021; 65(4):315-329. PubMed ID: 35087972
[TBL] [Abstract][Full Text] [Related]
25. Congenital pupillary-iris-lens membrane with goniodysgenesis: a rare cause of glaucoma and vision loss.
Demidenko A; Jakobiec FA; Hanna E; Walton DS
Int Ophthalmol Clin; 2009; 49(1):83-8. PubMed ID: 19125067
[No Abstract] [Full Text] [Related]
26. Bilateral irreversible severe vision loss from cosmetic iris implants.
George MK; Tsai JC; Loewen NA
Am J Ophthalmol; 2011 May; 151(5):872-875.e1. PubMed ID: 21310382
[TBL] [Abstract][Full Text] [Related]
27. Rubeosis and anterior segment ischemia associated with systemic cryoglobulinemia.
Telander DG; Holland GN; Wax MB; Van Gelder RN
Am J Ophthalmol; 2006 Oct; 142(4):689-90. PubMed ID: 17011871
[TBL] [Abstract][Full Text] [Related]
28. [Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].
Douat J; Auriol S; Mahieu-Durringer L; Ancèle E; Pagot-Mathis V; Mathis A
J Fr Ophtalmol; 2009 Nov; 32(9):652-63. PubMed ID: 19892433
[TBL] [Abstract][Full Text] [Related]
29. Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.
Saito Y; Higashide T; Takeda H; Murotani E; Ohkubo S; Sugiyama K
Am J Ophthalmol; 2010 Jun; 149(6):964-972.e1. PubMed ID: 20381786
[TBL] [Abstract][Full Text] [Related]
30. Ranibizumab as adjuvant in the treatment of rubeosis iridis and neovascular glaucoma--results from a prospective interventional case series.
Lüke J; Nassar K; Lüke M; Grisanti S
Graefes Arch Clin Exp Ophthalmol; 2013 Oct; 251(10):2403-13. PubMed ID: 23893090
[TBL] [Abstract][Full Text] [Related]
31. Intravitreal triamcinolone after intravitreal bevacizumab for retinal vein occlusions.
Jonas JB; Libondi T; Schlichtenbrede F; Schmidbauer M
Acta Ophthalmol; 2010 Mar; 88(2):e24-5. PubMed ID: 19493250
[No Abstract] [Full Text] [Related]
32. Central retinal vein occlusion: the therapeutic options.
Madhusudhana KC; Newsom RS
Can J Ophthalmol; 2007 Apr; 42(2):193-5. PubMed ID: 17392840
[No Abstract] [Full Text] [Related]
33. Intracameral bevacizumab in the treatment of neovascular glaucoma and exudative retinal detachment after brachytherapy in choroidal melanoma.
Vásquez LM; Somani S; Altomare F; Simpson ER
Can J Ophthalmol; 2009 Feb; 44(1):106-7. PubMed ID: 19169330
[No Abstract] [Full Text] [Related]
34. Diabetic iris neovascularization. Natural history and treatment.
Fernández-Vigo J; Castro J; Macarro A
Acta Ophthalmol Scand; 1997 Feb; 75(1):89-93. PubMed ID: 9088410
[TBL] [Abstract][Full Text] [Related]
35. Panretinal photocoagulation and photodynamic therapy for anterior segment neovascularization secondary to ischemic central retinal vein occlusion.
Parodi MB; Friberg TR; Pedio M; Fiotti N; Di Stefano G; Ravalico G
Ophthalmic Surg Lasers Imaging; 2007; 38(2):94-9. PubMed ID: 17396687
[TBL] [Abstract][Full Text] [Related]
36. Management of neovascular glaucoma with panretinal photocoagulation, intravitreal bevacizumab, and subsequent trabeculectomy with mitomycin C.
Alkawas AA; Shahien EA; Hussein AM
J Glaucoma; 2010 Dec; 19(9):622-6. PubMed ID: 20179624
[TBL] [Abstract][Full Text] [Related]
37. Retinal ischemia and angle neovascularization in proliferative diabetic retinopathy.
Hamanaka T; Akabane N; Yajima T; Takahashi T; Tanabe A
Am J Ophthalmol; 2001 Nov; 132(5):648-58. PubMed ID: 11704026
[TBL] [Abstract][Full Text] [Related]
38. Dexamethasone implants and neovascular glaucoma in central retinal vein occlusion.
Joshi L; Tomkins-Netzer O; Menezo V; Sallam A; Kirkpatrick N; Lightman S; Taylor SR
Acta Ophthalmol; 2013 May; 91(3):e239-40. PubMed ID: 23241218
[No Abstract] [Full Text] [Related]
39. Intravitreal bevacizumab (Avastin) injection in ocular ischemic syndrome.
Amselem L; Montero J; Diaz-Llopis M; Pulido JS; Bakri SJ; Palomares P; Garcia-Delpech S
Am J Ophthalmol; 2007 Jul; 144(1):122-4. PubMed ID: 17601432
[TBL] [Abstract][Full Text] [Related]
40. Vascular endothelial growth factor is sufficient to produce iris neovascularization and neovascular glaucoma in a nonhuman primate.
Tolentino MJ; Miller JW; Gragoudas ES; Chatzistefanou K; Ferrara N; Adamis AP
Arch Ophthalmol; 1996 Aug; 114(8):964-70. PubMed ID: 8694732
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
